http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0232414-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d039ed0eab17f552536fad58442db9db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2001-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5761da428746d6bd4458187211126863
publicationDate 2003-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0232414-A3
titleOfInvention Ribavirin-pegylated interferon alfa hcv combination therapy
abstract The use of ribavirin and/or pegylated interferon alfa for the preparation of a pharmaceutical composition for the treatment of chronic hepatitis C infection comprising a therapeutically weight-effective amount of ribavirin and a therapeutically effective amount of pegylated, e.g, pegylated interferon-alfa-2b or -2a, is disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7635689-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7662798-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7384924-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287311-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7547704-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9549941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9045520-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7608600-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9393256-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8957046-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7192936-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9394331-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7824851-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8492539-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7625875-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7365057-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9585906-B2
priorityDate 2000-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0037096-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0037110-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0956861-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9716204-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848

Total number of triples: 48.